Hereditary blindness caused by a progressive degeneration of the light-sensing cells in the eye, the photoreceptors, affects millions of people worldwide. Although the light-sensing cells are lost, cells in deeper layers of the retina, which normally cannot sense light, remain intact. A promising new therapeutic approach based on a technology termed “optogenetics” is to introduce […]Leer Más "A STEP TOWARD A POTENTIAL THERAPY FOR ACQUIRED BLINDNESS"
Five projects pave the way for the audacious goal of restoring vision to the blind Five bold projects will develop new technology to noninvasively image cells of the eye in unprecedented detail. The National Eye Institute (NEI) announced the awards as part of its Audacious Goals Initiative. NEI has committed $3.8 million to the projects […]Leer Más "NIH LAUNCHES RESEARCH TO GAZE DEEPLY INTO YOUR EYES"
Researchers have developed an antioxidant gene therapy that slows cone-cell death and prolongs vision in mouse models of retinal degeneration. Led by Harvard Medical School geneticist Connie Cepko and postdoctoral researcher Wenjun Xiong, the research team hopes the work will one day lead to new treatment options for people with inherited progressive blindness, such as […]Leer Más "SEEING THE LIGHT: GENE THERAPY SLOWS VISION LOSS IN MOUSE MODELS OF RETINAL DEGENERATION"